Telix Pharmaceuticals (TLX) Work In Process (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Telix Pharmaceuticals (TLX) has disclosed Work In Process for 2 consecutive years, with $9.1 million as the latest value for Q4 2024.

• Quarterly Work In Process rose 133.94% to $9.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2024, up 133.94% year-over-year, with the annual reading at $9.1 million for FY2024, 133.94% up from the prior year.
• Work In Process for Q4 2024 was $9.1 million at Telix Pharmaceuticals, up from $3.9 million in the prior quarter.
• The five-year high for Work In Process was $9.1 million in Q4 2024, with the low at $3.9 million in Q4 2023.

Peer Comparison